Brainomix has announced its involvement in a new study sponsored by the University of Liverpool focused on post-stroke atrial fibrillation (AF). Sites with existing clinical deployments of Brainomix’s e-Stroke platform will utilize the AI system to collect real-time imaging data and securely transfer to the central investigators. The Liverpool-Huawei Stroke Study aims to determine the clinical effectiveness, cost effectiveness, and acceptability of Huawei Smartwear to detect AF in patients following an acute ischemic stroke. Ultimately, the aim...